» Articles » PMID: 36929422

NONHSAG028908.3 Sponges MiR‑34a‑5p to Promote Growth of Colorectal Cancer Via Targeting ALDOA

Overview
Journal Oncol Rep
Specialty Oncology
Date 2023 Mar 17
PMID 36929422
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer (CRC) is an aggressive tumor, whose development is considered to be modulated by certain long non‑coding RNAs (lncRNAs). Therefore, the aim of the present study was to investigate the regulatory mechanism of lncRNA NONHSAG028908.3 on CRC. Data from The Cancer Genome Atlas (TCGA) database revealed that NONHSAG028908.3 was increased in CRC tissues compared with normal tissues (P<0.001). The results of reverse transcription‑quantitative PCR indicated that NONHSAG028908.3 was upregulated in four types of CRC cells compared with that in NCM460, a normal colorectal cell line. MTT, BrdU, and flow cytometric assays were applied to evaluate CRC cell growth. The migratory and invasive abilities of CRC cells were detected using wound healing and Transwell assays. Silencing of NONHSAG028908.3 inhibited proliferation, migration, and invasion of CRC cells. A dual‑luciferase reporter assay demonstrated that NONHSAG028908.3 served as a sponge to combine with microRNA (miR)‑34a‑5p. MiR‑34a‑5p suppressed the aggressiveness of CRC cells. The effects induced by NONHSAG028908.3 knockdown were partly reversed by inhibition of miR‑34a‑5p. Furthermore, miR‑34a‑5p, a target of NONHSAG028908.3, modulated aldolase, fructose‑bisphosphate A (ALDOA) expression in a negative feedback manner. Suppression of NONHSAG028908.3 notably decreased ALDOA expression, which was rescued via silencing of miR‑34a‑5p. Moreover, suppression of ALDOA revealed the inhibitory action on CRC cell growth and migration. In summary, the data of the present study indicate that NONHSAG028908.3 may positively regulate ALDOA via sponging miR‑34a‑5p, thereby promoting malignant activities in CRC.

Citing Articles

promotes colorectal cancer malignant progression by binding with IGF2BP1 to enhance the stability of connective tissue growth factor mRNA.

Lun W, Zhang X, Hong Y, Luo C, Liu Y Epigenomics. 2024; 16(14):985-998.

PMID: 39072366 PMC: 11404617. DOI: 10.1080/17501911.2024.2373686.


MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential.

Fu J, Imani S, Wu M, Wu R Cancers (Basel). 2023; 15(19).

PMID: 37835417 PMC: 10571940. DOI: 10.3390/cancers15194723.


Effect of miR-34a on the expression of clock and clock-controlled genes in DLD1 and Lovo human cancer cells with different backgrounds with respect to p53 functionality and 17β-estradiol-mediated regulation.

Moravcik R, Olejarova S, Zlacka J, Herichova I PLoS One. 2023; 18(10):e0292880.

PMID: 37831728 PMC: 10575541. DOI: 10.1371/journal.pone.0292880.

References
1.
Bian Z, Zhang J, Li M, Feng Y, Wang X, Zhang J . LncRNA-FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling. Clin Cancer Res. 2018; 24(19):4808-4819. DOI: 10.1158/1078-0432.CCR-17-2967. View

2.
Li Y, Zeng C, Hu J, Pan Y, Shan Y, Liu B . Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression. J Hematol Oncol. 2018; 11(1):89. PMC: 6029165. DOI: 10.1186/s13045-018-0632-2. View

3.
Tang J, Yan T, Bao Y, Shen C, Yu C, Zhu X . LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc. Nat Commun. 2019; 10(1):3499. PMC: 6677832. DOI: 10.1038/s41467-019-11447-8. View

4.
Lunt S, Vander Heiden M . Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol. 2011; 27:441-64. DOI: 10.1146/annurev-cellbio-092910-154237. View

5.
Dai L, Pan G, Liu X, Huang J, Jiang Z, Zhu X . High expression of ALDOA and DDX5 are associated with poor prognosis in human colorectal cancer. Cancer Manag Res. 2018; 10:1799-1806. PMC: 6029611. DOI: 10.2147/CMAR.S157925. View